Outcomes in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention in the Current Era: A Report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) Trial

Circulation

Volumn 109, Issue 4, 2004, Pages 476-480

  Mathew, Verghese ^a   Gersh, Bernard J ^a   Williams, Brent A ^a   Laskey, Warren K ^a   Willerson, James T ^a   Tilbury, R Thomas ^a   Davis, Barry R ^a   Holmes Jr , David R ^a  

^a MAYO CLINIC   (United States)

Author keywords

Coronary disease; Diabetes mellitus; Revascularization

Indexed keywords

ABCIXIMAB; FIBRINOGEN RECEPTOR ANTAGONIST; PLACEBO; TRANILAST;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; CORRELATION ANALYSIS; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; RISK ASSESSMENT; SEX DIFFERENCE; SURGICAL TECHNIQUE; UNSTABLE ANGINA PECTORIS;

ANTHRANILIC ACIDS; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; STENTS; TREATMENT OUTCOME;

EID: 0842285794     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000109693.64957.20     Document Type: Article

References (16)

1. Marso S, Lincoff A, Ellis S, et al. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial) diabetic substudy. Circulation. 1999;100:2477-2484.
2. Velianou J, Mathew V, Wilson S, et al. Effect of abciximab on late adverse events in patients with diabetes mellitus undergoing stent implantation. Am J Cardiol. 2000;86:1063-1068.
3. Holmes DJ, Fitzgerald P, Goldberg S, et al. The PRESTO (Prevention of Restenosis with Tranilast and its Outcomes) protocol: a double-blind, placebo-controlled trial. Am Heart J. 2000;139:23-31.
4. Holmes DJ, Savage M, LaBlanche J, et al. Results of the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) Trial. Circulation. 2002;106:1243-1250.
5. BARI Investigators. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation. 1997;96:1761-1769.
6. Detre K, Guo P, Holubkov R, et al. Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Bypass Angioplasty Revascularization Investigation (BARI). Circulation. 1999;99:633-640.
7. Barsness G, Peterson E, Ohman E, et al. Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. Circulation. 1997;96:2551-2556.
8. Niles N, McGrath P, Malenka D, et al. Northern New England Cardiovascular Disease Study Group survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. J Am Coll Cardiol. 2001;37:1008-1015.
9. Stein B, Weintraub W, Gebhart S, et al. Coronary heart disease/ myocardial infarction: Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation. 1995;91:979-989.
10. Van Belle E, Abolmaali K, Bauters C, et al. Restenosis, late vessel occlusion and left ventricular function six months after balloon angioplasty in diabetic patients. J Am Coll Cardiol. 1999;34:476-485.
11. Van Belle E, Ketelers R, Bauters C, et al. Patency of percutaneous transluminal coronary angioplasty sites at 6-month angiographic follow-up: a key determinant of survival in diabetics after coronary balloon angioplasty. Circulation. 2001;103:1218-1224.
12. Van Belle E, Perie M, Braune D, et al. Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients. J Am Coll Cardiol. 2002;40:410-417.
13. Aronson D, Bloomgarden Z, Rayfield E. Potential mechanisms promoting restenosis in diabetic patients. J Am Coll Cardiol. 1996;27:528-535.
14. Rozenman Y, Sapoznikov D, Mosseri M, et al. Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus: a clue to the explanation of the results of the BARI study. J Am Coll Cardiol. 1997;30:1420-1425.
15. Barsness G, Hardison R, Detre K, et al. Lesion progression and restenosis in PTCA-treated diabetic and non-diabetic patients with multivessel disease. Circulation. 2000;102(suppl II):II-479.
16. Laskey W, Selzer F, Vlachos H, et al. Comparison of in-hospital and one-year outcomes in patients with and without diabetes mellitus undergoing percutaneous catheter intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry). Am J Cardiol. 2002;90: 1062-1067.